NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Thursday reported second-quarter earnings of $102 million.
On a per-share basis, the New York-based company said it had profit of 17 cents. Earnings, adjusted for non-recurring costs, were 96 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 95 cents per share.
The company posted revenue of $537 million in the period. Its adjusted revenue was $608 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
